Merck Buying Schering-Plough in $41B Deal

by Benjamin Domenech on 8:48 am March 9, 2009

TRENTON, N.J. (AP) — Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in stock and cash in a deal that gives the companies more firepower to compete in a drug industry facing slumping sales, tough generic competition and intense pricing pressures.

Previous post:

Next post: